| Fenofibrate | Approved Investigational | AQP9 | 366 |
downregulated | Fenofibrate results in decreased expression of AQP9 mRNA | 15q21.3 | |
| Fenofibrate | Approved Investigational | ARFGEF2 | 10564 |
upregulated | Fenofibrate results in increased expression of ARFGEF2 mRNA | 20q13.13 | |
| Fenofibrate | Approved Investigational | ASNS | 440 |
upregulated | Fenofibrate results in increased expression of ASNS mRNA | 7q21.3 | |
| Fenofibrate | Approved Investigational | ATF3 | 467 |
upregulated | Fenofibrate results in increased expression of ATF3 mRNA | 1q32.3 | |
| Fenofibrate | Approved Investigational | ATP2B4 | 493 |
upregulated | Fenofibrate results in increased expression of ATP2B4 mRNA | 1q32.1 | |
| Fenofibrate | Approved Investigational | BCAT1 | 586 |
downregulated | Fenofibrate results in decreased expression of BCAT1 mRNA | 12p12.1 | |
| Fenofibrate | Approved Investigational | BCAT2 | 587 |
upregulated | Fenofibrate results in increased expression of BCAT2 mRNA | 19q13.33 | |
| Fenofibrate | Approved Investigational | BCL2 | 596 |
downregulated | Fenofibrate results in decreased expression of BCL2 mRNA | 18q21.33 | |
| Fenofibrate | Approved Investigational | BCL2A1 | 597 |
downregulated | Fenofibrate results in decreased expression of BCL2A1 mRNA | 15q25.1 | |
| Fenofibrate | Approved Investigational | BCL2L1 | 598 |
downregulated | Fenofibrate results in decreased expression of BCL2L1 mRNA | 20q11.21 | |
| Fenofibrate | Approved Investigational | BCL3 | 602 |
downregulated | Fenofibrate results in decreased expression of BCL3 mRNA | 19q13.32 | |
| Fenofibrate | Approved Investigational | BHLHE40 | 8553 |
downregulated | Fenofibrate results in decreased expression of BHLHE40 mRNA | 3p26.1 | |
| Fenofibrate | Approved Investigational | BIRC3 | 330 |
downregulated | Fenofibrate results in decreased expression of BIRC3 mRNA | 11q22.2 | |
| Fenofibrate | Approved Investigational | BMF | 90427 |
upregulated | Fenofibrate results in increased expression of BMF mRNA | 15q15.1 | |
| Fenofibrate | Approved Investigational | CAV1 | 857 |
upregulated | Fenofibrate results in increased expression of CAV1 mRNA | 7q31.2 | |
| Fenofibrate | Approved Investigational | CCL13 | 6357 |
upregulated | Fenofibrate results in increased expression of CCL13 mRNA | 17q12 | |
| Fenofibrate | Approved Investigational | CCND1 | 595 |
downregulated | Fenofibrate results in decreased expression of CCND1 mRNA | 11q13.3 | |
| Fenofibrate | Approved Investigational | CCNG2 | 901 |
downregulated | Fenofibrate results in decreased expression of CCNG2 mRNA | 4q21.1 | |
| Fenofibrate | Approved Investigational | CD14 | 929 |
upregulated | Fenofibrate results in increased expression of CD14 mRNA | 5q31.3 | |
| Fenofibrate | Approved Investigational | CD36 | 948 |
upregulated | Fenofibrate results in increased expression of CD36 mRNA | 7q21.11 | |
| Fenofibrate | Approved Investigational | CD40 | 958 |
downregulated | Fenofibrate results in decreased expression of CD40 mRNA | 20q13.12 | |
| Fenofibrate | Approved Investigational | CDK20 | 23552 |
upregulated | Fenofibrate results in increased expression of CDK20 mRNA | 9q22.1 | |
| Fenofibrate | Approved Investigational | CPT1A | 1374 |
upregulated | Fenofibrate results in increased expression of CPT1A mRNA | 11q13.3 | |
| Fenofibrate | Approved Investigational | CPT2 | 1376 |
upregulated | Fenofibrate results in increased expression of CPT2 mRNA | 1p32.3 | |
| Fenofibrate | Approved Investigational | CREB3L3 | 84699 |
upregulated | Fenofibrate results in increased expression of CREB3L3 mRNA | 19p13.3 | |